This is the text extract for 2010-07 Schedule Dispatch , browse documents here.

---

17 June 2010

July 2010 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the July 2010 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details.

New listings · Potassium iodate (Neurokare) tab 268 µg (150 µg elemental) (p’code 2359405) · Danthron with poloxamer (Pinorax) oral liq 25 mg with poloxamer 200 mg per 5 ml – only on a prescription – only for the prevention or treatment of constipation in the terminally ill (p’code 2259435) · Multivitamins (Paediatric Seravit) powder, 200 g OP – Special Authority – Retail pharmacy (p’code 2361329) · Vitamins (MultiADE) tab (BPC cap strength) (p’code 2360861) · Amlodipine (Norvasc) tab 5 mg (p’code: 777765) and 10 mg (p’code 777757) · Tretinoin (ReTrieve) crm 0.5 mg per g – maximum of 50 g per prescription (p’code 2358751) · Coal tar (Midwest) soln BP, 200 ml – only in combination (p’code 2361671) · Oestradiol (Estradot 50 mcg) TDDS 50 µg per day – Higher subsidy with Special Authority, no more than 2 patches per week, only on a prescription (p’code 2358867) · Clomiphene citrate (Serophene) tab 50 mg (p’code 731544) · Lopinavir with ritonavir (Kaletra) tab 100 mg with ritonavir 25 mg – Special Authority – Hospital pharmacy [HP1] (p’code 2360969) · Fluoxetine hydrochloride (Fluox) cap 20 mg, 84 cap pack (p’code 2353121) · Flumetasone pivalate (Locacorten-Vioform ED’s) ear drops 0.02% with clioquinol 1% (p’code 2360403) · Glycerol (healthE) liquid, 2,000 ml – only in combination, only in extemporaneously compounded oral liquid preparations (p’code 2341018) · Protein supplement (Resource Beneprotein) powder, 227 g OP – Special Authority – Hospital pharmacy [HP3] (p’code 2264471) · Aminoacid formula with minerals without phenylalanine (Metabolic Mineral Mixture) powder, 100 g OP – Special Authority – Retail pharmacy (p’code 2036711) Changes to restrictions · Clotrimazole (Clomazol) vaginal crm 1% with applicators – amended presentation · Hormone replacement therapy – systemic – amended Special Authority criteria · Clomiphene citrate – removal of Retail pharmacy-Specialist and only a prescription for a female patient restrictions · Dapsone (Dapsone) tab 25 mg and 100 mg – addition of Section 29 · Antiretrovirals – amended Special Authority criteria · Influenza vaccine (Fluvax, Influvac, Vaxigrip) inj – extended season · Domperidone (Motilium) tab 10 mg – removal of Additional subsidy by Special Authority · Tolcapone (Tasmar) tab 100 mg – removal of Retail pharmacy-Specialist prescription · Octreotide (somatostatin analogue) (Hospira, Sandostatin) inj 50 µg per ml, 1 ml, 100 µg per ml, 1 ml, and 500 µg per ml, 1 ml, and (Sandostatin LAR) inj LAR prefilled syringe 10 mg, 20 mg and 30 mg – amended Special Authority criteria · Trastuzumab (Herceptin) inj 150 mg vial and 440 mg vial, and (Baxter) inj 1 mg for ECP – amended Special Authority criteria

A362335 Page 1 of 3

---

Decreased subsidy

Chemical Presentation Fully brands subsidised Partially subsidised brands Aspec 300 Ethics Aspirin Arrow-Bendrofluazide Lax-Tabs Arrow-Cabergoline Dostinex Ranbaxy-Cefaclor PSM Baxter Clomazol Clomazol MidWest PSM Pedialyte – Bubblegum Pedialyte – Fruit Pedialyte - Plain Baxter Fluox Fluox Foban Foban Gemcitabine Ebewe Baxter ABM healthE PSM Micreme H Fenpaed Loraclear Hayfever Relief Lorapaed Betaloc CR Metoprolol – AFT CR Betaloc CR Metoprolol – AFT CR Betaloc CR Metoprolol – AFT CR Betaloc CR Metoprolol – AFT CR Mitozantrone Ebewe Baxter Loxamine Dr Reddy’s Pantoprazole David Craig Neo-Naclex

Aspirin

Bendrofluazide Bisacodyl Cabergoline Cefaclor monohydrate Cetomacrogol Cisplatin Clotrimazole

Tab 100 mg Tab EC 300 mg Tab dispersible 300 mg Tab 2.5 mg and 5 mg Tab 5 mg Tab 0.5 mg Grans for oral liq 125 mg per 5 ml Crm BP Inj 1 mg for ECP Vaginal crm 1% with applicatiors Vaginal crm 2% with applicators Soln BP Soln with electrolytes

Ethics Aspirin EC

Coal tar Dextrose with electrolytes

Docetaxel Fluoxetine hydrochloride Fusidic acid Gemcitabine hydrochloride Glycerol

Inj 1 mg for ECP Tab dispersible 20 mg, scored Cap 20 mg, 90 cap pack Crm 2% Oint 2% Inj 200 mg and 1 g Inj 1 mg for ECP Liquid, 2,000 ml

Midwest

Hydrocortisone with miconazole Ibuprofen Loratadine

Crm 1% with miconazole nitrate 2% Oral liq 100 mg per 5 ml Tab 10 mg Oral liq 1 mg per ml Tab long-acting 23.75 mg Tab long-acting 47.5 mg Tab long-acting 95 mg Tab long-acting 190 mg

Metoprolol succinate

Mitozantrone Paroxetine hydrochloride Pantoprazole

Inj 2 mg per ml, 10 mg Inj 1 mg for ECP Tab 20 mg Tab 20 mg and 40 mg

A362335 Page 2 of 3

---

Phenoxymethylpenicillin (Penicillin V) Ropinirole hydrochloride Salabutamol Spironolactone Testosterone undecanoate

Grans for oral liq 250 mg per 5 ml Tab 0.25 mg, 1 mg, 2 mg and 5 mg Oral liq 2 mg per 5 ml Tab 25 mg and 100 mg Cap 40 mg

AFT Ropin Salapin Spirotone Arrow-Testosterone Andriol Testocaps

Panteston

Increased subsidy

Chemical Domperidone Oral elemental feed 1kcal/ml Oral supplement 1kcal/ml Presentation Tab 10 mg Powder (unflavoured) Powder (chocolate) Powder (vanilla) Phenytoin sodium Tab 50 mg Cap 30 mg and 100 mg Oral liq 30 mg per 5 ml Fully brands subsidised

Motilium Vivonex TEN Sustagen Hospital Formula Sustagen Hospital Formula Dilantin Infatab Dilantin Dilantin

NB. For further details and magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule.

A362335 Page 3 of 3